{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:07:25Z","timestamp":1774958845036,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1111\/ijcp.12955","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T23:44:58Z","timestamp":1493336698000},"page":"e12955","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A randomised, double-blind, trial of the safety and efficacy of omarigliptin (a once-weekly DPP-4 inhibitor) in subjects with type 2 diabetes and renal impairment"],"prefix":"10.1155","volume":"71","author":[{"given":"Antonio","family":"Chacra","sequence":"first","affiliation":[{"name":"Diabetes Center; Federal University of Sao Paulo; Sao Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6565-7113","authenticated-orcid":false,"given":"Ira","family":"Gantz","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Kenilworth NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldine","family":"Mendizabal","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Kenilworth NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucila","family":"Durlach","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Kenilworth NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"O'Neill","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Kenilworth NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Kenilworth NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailaja","family":"Suryawanshi","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Kenilworth NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel S.","family":"Engel","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Kenilworth NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eseng","family":"Lai","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.; Kenilworth NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"key":"10.1111\/ijcp.12955-BIB0001|ijcp12955-cit-0001","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/sj.ki.5000377","article-title":"Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective","volume":"69","author":"Parving","year":"2006","journal-title":"Kidney Int"},{"issue":"305","key":"10.1111\/ijcp.12955-BIB0002|ijcp12955-cit-0002","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2011.861","article-title":"Temporal trends in the prevalence of diabetic kidney disease in the United States","volume":"22","author":"Boer","year":"2011","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12955-BIB0003|ijcp12955-cit-0003","unstructured":"National Center for Health Statistics: Health, United States, 2014: With Special Feature on Adults Aged 55-64, Table 45 http:\/\/www.cdc.gov\/nchs\/data\/hus\/hus14.pdf"},{"key":"10.1111\/ijcp.12955-BIB0004|ijcp12955-cit-0004","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ijcp.12955-BIB0005|ijcp12955-cit-0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40842-015-0001-9","article-title":"Management of diabetes mellitus in patients with chronic kidney disease","volume":"1","author":"Hahr Allison","year":"2015","journal-title":"Clin Diabetes Endocrinol"},{"key":"10.1111\/ijcp.12955-BIB0006|ijcp12955-cit-0006","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.2014.15298","article-title":"Metformin in patients with type 2 diabetes and kidney disease: a systematic review","volume":"312","author":"Inzucchi","year":"2014","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12955-BIB0007|ijcp12955-cit-0007","unstructured":"FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function 2016 http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm493244.htm"},{"key":"10.1111\/ijcp.12955-BIB0008|ijcp12955-cit-0008","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1185\/030079906X162746","article-title":"Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes","volume":"23","author":"Pratley","year":"2007","journal-title":"CurrMed Res Opin"},{"key":"10.1111\/ijcp.12955-BIB0009|ijcp12955-cit-0009","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12955-BIB0010|ijcp12955-cit-0010","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1021\/jm401992e","article-title":"Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes","volume":"57","author":"Biftu","year":"2014","journal-title":"J Med Chem"},{"issue":"S1","key":"10.1111\/ijcp.12955-BIB0011|ijcp12955-cit-0011","first-page":"S55","article-title":"Effect of omarigliptin, a novel once-weekly DPP-4 inhibitor, in Japanese patients with type 2 diabetes: a placebo- and sitagliptin-controlled trial","volume":"57","author":"Gantz","year":"2014","journal-title":"Diabetologia"},{"issue":"S1","key":"10.1111\/ijcp.12955-BIB0012|ijcp12955-cit-0012","first-page":"S54","article-title":"Omarigliptin, a once-weekly DPP-4 inhibitor, provides similar glycemic control to sitagliptin in patients with T2DM inadequately controlled on metformin","volume":"58","author":"Gantz","year":"2015","journal-title":"Diabetologia"},{"key":"10.1111\/ijcp.12955-BIB0013|ijcp12955-cit-0013","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/ijcp.12955-BIB0014|ijcp12955-cit-0014","first-page":"134","article-title":"Longitudinal data analysis of continuous and discrete responses for pre-post designs","volume":"62","author":"Liang","year":"2000","journal-title":"Indian J Stat"},{"key":"10.1111\/ijcp.12955-BIB0015|ijcp12955-cit-0015","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"Rubin","year":"1987"},{"key":"10.1111\/ijcp.12955-BIB0016|ijcp12955-cit-0016","first-page":"213","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"StatMed"},{"key":"10.1111\/ijcp.12955-BIB0017|ijcp12955-cit-0017","unstructured":"MSSO: Introductory Guide MedDRA Version 17.1 2014 http:\/\/www.meddra.org\/sites\/default\/files\/guidance\/file\/intguide_17_1_english.pdf"},{"issue":"S1","key":"10.1111\/ijcp.12955-BIB0018|ijcp12955-cit-0018","first-page":"S90","article-title":"Pharmacokinetics of omarigliptin (MK-3102), a once weekly dipeptidyl peptidase-IV (DPP-4) inhibitor, in patients with renal impairment","volume":"95","author":"Tatosian","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/ijcp.12955-BIB0019|ijcp12955-cit-0019","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/dc12-1365","article-title":"Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency","volume":"36","author":"Arjona Ferreira","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12955-BIB0020|ijcp12955-cit-0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1463-1326.2008.00914.x","article-title":"Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency","volume":"10","author":"Chan","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/ijcp.12955-BIB0021|ijcp12955-cit-0021","doi-asserted-by":"crossref","first-page":"835","DOI":"10.4239\/wjd.v5.i6.835","article-title":"Risks of rapid decline renal function in patients with type 2 diabetes","volume":"5","author":"Sheen","year":"2014","journal-title":"World J Diabetes"},{"key":"10.1111\/ijcp.12955-BIB0022|ijcp12955-cit-0022","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/jcph.773","article-title":"Pharmacokinetics and pharmacodynamics of Omarigliptin, a once-weekly Dipeptidyl Peptidase-4 (DPP-4) inhibitor, after single and multiple doses in healthy subjects","volume":"56","author":"Krishna","year":"2016","journal-title":"J\u00a0Clin Pharmacol"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12955","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ijcp.12955\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:10:08Z","timestamp":1643350208000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12955","archive":["Portico"],"relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}